Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide and Sirolimus Maintenance Post-Transplant for High-Risk Multiple Myeloma
NCT01303965Phase 2Terminated
- Start
- Feb 2011
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide, sirolimus in multiple myeloma (MM). Started Feb 2011; status: terminated.
02
Drugs
lenalidomidesirolimus
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01303965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01303965.